Profile data is unavailable for this security.
About the company
BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.
- Revenue in USD (TTM)27.00k
- Net income in USD-25.25m
- Incorporated2011
- Employees4.00
- LocationBioSig Technologies Inc55 Greens Farms RoadWESTPORT 06880United StatesUSA
- Phone+1 (203) 409-5444
- Fax+1 (302) 645-1280
- Websitehttps://www.biosig.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nu-Med Plus Inc | 0.00 | -119.16k | 4.75m | 2.00 | -- | -- | -- | -- | -0.0014 | -0.0014 | 0.00 | -0.002 | 0.00 | -- | -- | 0.00 | -350.01 | -447.69 | -- | -- | -- | -- | -- | -- | -- | -22.74 | -- | -- | -- | -- | 3.56 | -- | -- | -- |
| Aethlon Medical, Inc. | 0.00 | -12.21m | 5.11m | 14.00 | -- | 0.1676 | -- | -- | -4.87 | -4.87 | 0.00 | 2.19 | 0.00 | -- | -- | 0.00 | -94.80 | -76.25 | -108.90 | -85.78 | -- | -- | -- | -2,246.87 | -- | -- | 0.00 | -- | -100.00 | -- | -1.43 | -- | -- | -- |
| Caduceus Software Systems Corp | 0.00 | -117.60k | 5.35m | 0.00 | -- | -- | -- | -- | -0.0004 | -0.0004 | 0.00 | -0.0004 | 0.00 | -- | -- | -- | -402.19 | -11,090.31 | -- | -- | -- | -- | -- | -- | -- | -76.88 | -- | -- | -- | -- | -20,519.89 | -- | -- | -- |
| ADM Tronics Unlimited Inc | 2.97m | -877.23k | 5.35m | 7.00 | -- | 7.73 | -- | 1.81 | -0.013 | -0.013 | 0.0439 | 0.0102 | 1.13 | 4.89 | 7.04 | -- | -33.56 | -15.22 | -58.66 | -22.09 | 37.65 | 41.15 | -29.58 | -18.58 | 0.8015 | -316.56 | 0.4233 | -- | -19.35 | -0.3572 | -810.74 | -- | -- | -- |
| Sonendo Inc | 40.19m | -57.74m | 5.39m | 216.00 | -- | 0.2197 | -- | 0.1341 | -0.6125 | -0.5552 | 0.426 | 0.3482 | 0.4448 | 2.07 | 7.58 | 186,055.60 | -63.91 | -- | -78.82 | -- | 27.64 | -- | -143.67 | -- | 2.14 | -10.83 | 0.4695 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
| Predictive Oncology Inc | 1.96m | -14.78m | 5.66m | 34.00 | -- | 1.38 | -- | 2.89 | -3.66 | -3.66 | 0.4853 | 0.9977 | 0.1099 | 1.71 | 4.95 | 57,642.65 | -82.89 | -91.80 | -108.54 | -126.29 | 64.18 | 64.64 | -754.19 | -1,419.99 | 1.35 | -- | 0.0093 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
| Biomerica Inc | 5.41m | -6.35m | 5.84m | 62.00 | -- | 0.748 | -- | 1.08 | -0.3789 | -0.3789 | 0.3224 | 0.4642 | 0.5827 | 2.28 | 5.74 | 87,180.80 | -68.45 | -43.55 | -83.73 | -50.32 | 11.41 | 15.75 | -117.46 | -55.86 | 3.37 | -- | 0.00 | -- | -71.71 | -0.8229 | -57.58 | -- | -9.76 | -- |
| ALR Technologies Inc | 9.49k | -8.00m | 6.35m | 6.00 | -- | -- | -- | 669.62 | -0.0147 | -0.0147 | 0.00002 | -0.0476 | 0.0358 | -- | -- | 1,581.67 | -3,015.28 | -12,861.64 | -- | -- | 62.49 | -- | -84,283.24 | -406,011.30 | -- | -0.8626 | -- | -- | -- | -- | -42.72 | -- | -- | -- |
| Sigyn Therapeutics Inc | 0.00 | -3.56m | 6.43m | 5.00 | -- | -- | -- | -- | -3.04 | -3.04 | 0.00 | -3.28 | 0.00 | -- | -- | 0.00 | -724.37 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0199 | -1.92 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
| BioSig Technologies Inc | 27.00k | -25.25m | 6.49m | 4.00 | -- | -- | -- | 240.28 | -3.24 | -3.24 | 0.0033 | -0.3776 | 0.008 | -- | 1.74 | 6,750.00 | -728.65 | -269.73 | -- | -363.11 | 48.15 | -- | -91,566.66 | -24,485.73 | -- | -- | -- | -- | -93.71 | -- | -6.52 | -- | -9.58 | -- |
| Telesis Bio Inc | 24.63m | -47.13m | 6.86m | 137.00 | -- | -- | -- | 0.2784 | -28.31 | -28.31 | 14.80 | 12.94 | 0.3231 | 3.27 | 5.58 | 179,802.90 | -59.34 | -- | -67.10 | -- | 60.43 | -- | -183.66 | -- | 3.08 | -35.89 | 0.2015 | -- | 0.2697 | -- | -1.14 | -- | -- | -- |
| Innovative Eyewear Inc | 1.39m | -7.20m | 7.31m | 11.00 | -- | 0.8887 | -- | 5.25 | -12.15 | -12.15 | 2.35 | 5.90 | 0.2803 | 1.89 | 15.42 | 126,457.30 | -145.15 | -- | -168.75 | -- | -8.82 | -- | -517.88 | -- | 3.68 | -6,764.71 | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
| Neurometrix Inc | 5.27m | -7.98m | 7.44m | 26.00 | -- | 0.392 | -- | 1.41 | -6.32 | -6.32 | 4.20 | 9.44 | 0.2381 | 1.25 | 10.08 | 202,700.40 | -36.07 | -23.24 | -38.94 | -27.26 | 61.97 | 59.17 | -151.51 | -48.88 | 10.11 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
| Guided Therapeutics Inc | 82.00k | -3.23m | 7.74m | 4.00 | -- | -- | -- | 94.36 | -0.0623 | -0.0623 | 0.0016 | -0.0721 | 0.0374 | 0.0904 | 11.71 | 20,500.00 | -137.80 | -136.13 | -- | -- | 32.93 | 29.39 | -3,685.37 | -3,666.67 | 0.1138 | -11.13 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
| Vivos Therapeutics Inc | 13.36m | -15.64m | 7.75m | 114.00 | -- | 11.26 | -- | 0.5796 | -11.00 | -11.00 | 8.73 | 0.2131 | 0.9247 | -- | 31.59 | 117,219.30 | -108.24 | -89.72 | -243.30 | -149.70 | 58.90 | 70.20 | -117.06 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
| Precipio Inc | 15.81m | -4.90m | 8.14m | 51.00 | -- | 0.6203 | -- | 0.5149 | -3.73 | -3.73 | 11.60 | 8.93 | 0.8773 | 17.85 | 17.93 | 310,039.20 | -27.20 | -44.98 | -34.82 | -58.68 | 39.14 | 28.80 | -31.00 | -118.07 | 0.6201 | -350.95 | 0.0278 | -- | 61.46 | 39.62 | 52.04 | -- | 5.37 | -- |
Data as of Jul 26 2024. Currency figures normalised to BioSig Technologies Inc's reporting currency: US Dollar USD
1.97%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| PFG Investments LLCas of 31 Mar 2024 | 106.15k | 0.75% |
| Geode Capital Management LLCas of 31 May 2024 | 53.23k | 0.38% |
| Jane Street Capital LLCas of 31 Mar 2024 | 43.82k | 0.31% |
| HRT Financial LLCas of 31 Mar 2024 | 26.33k | 0.19% |
| Commonwealth Equity Services LLCas of 31 Mar 2024 | 12.50k | 0.09% |
| Virtu Americas LLCas of 31 Mar 2024 | 11.78k | 0.08% |
| Truist Bank (Private Banking)as of 31 Mar 2024 | 11.23k | 0.08% |
| Tower Research Capital LLCas of 31 Mar 2024 | 7.05k | 0.05% |
| Webster Financial Advisorsas of 30 Jun 2024 | 4.00k | 0.03% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 2.66k | 0.02% |
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
